Adoptive cell therapy for solid tumours

The next steps for effective cancer immunotherapy and viral vaccines

Combination immunotherapies and multi-modal treatment

Checkpoint inhibition in practice and in public

Managing cytokine release syndrome

Can we afford immunotherapy?

Multiorgan toxicity following combination immunotherapy treatment in melanoma

Predicting response to immunotherapy

Improving access to pathology in low resource settings

Pathology access and advocacy

Improving access to palliative care

Collaborative research and new frontiers in cancer research